Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 12;9(1):e12372.
doi: 10.1002/trc2.12372. eCollection 2023 Jan-Mar.

Development, initial validation, and application of a visual read method for [18F]MK-6240 tau PET

Affiliations

Development, initial validation, and application of a visual read method for [18F]MK-6240 tau PET

Joanna L Shuping et al. Alzheimers Dement (N Y). .

Abstract

Background: The positron emission tomography (PET) radiotracer [18F]MK-6240 exhibits high specificity for neurofibrillary tangles (NFTs) of tau protein in Alzheimer's disease (AD), high sensitivity to medial temporal and neocortical NFTs, and low within-brain background. Objectives were to develop and validate a reproducible, clinically relevant visual read method supporting [18F]MK-6240 use to identify and stage AD subjects versus non-AD and controls.

Methods: Five expert readers used their own methods to assess 30 scans of mixed diagnosis (47% cognitively normal, 23% mild cognitive impairment, 20% AD, 10% traumatic brain injury) and provided input regarding regional and global positivity, features influencing assessment, confidence, practicality, and clinical relevance. Inter-reader agreement and concordance with quantitative values were evaluated to confirm that regions could be read reliably. Guided by input regarding clinical applicability and practicality, read classifications were defined. The readers read the scans using the new classifications, establishing by majority agreement a gold standard read for those scans. Two naïve readers were trained and read the 30-scan set, providing initial validation. Inter-rater agreement was further tested by two trained independent readers in 131 scans. One of these readers used the same method to read a full, diverse database of 1842 scans; relationships between read classification, clinical diagnosis, and amyloid status as available were assessed.

Results: Four visual read classifications were determined: no uptake, medial temporal lobe (MTL) only, MTL and neocortical uptake, and uptake outside MTL. Inter-rater kappas were 1.0 for the naïve readers gold standard scans read and 0.98 for the independent readers 131-scan read. All scans in the full database could be classified; classification frequencies were concordant with NFT histopathology literature.

Discussion: This four-class [18F]MK-6240 visual read method captures the presence of medial temporal signal, neocortical expansion associated with disease progression, and atypical distributions that may reflect different phenotypes. The method demonstrates excellent trainability, reproducibility, and clinical relevance supporting clinical use.

Highlights: A visual read method has been developed for [18F]MK-6240 tau positron emission tomography.The method is readily trainable and reproducible, with inter-rater kappas of 0.98.The read method has been applied to a diverse set of 1842 [18F]MK-6240 scans.All scans from a spectrum of disease states and acquisitions could be classified.Read classifications are consistent with histopathological neurofibrillary tangle staging literature.

Keywords: Alzheimer's disease; MK‐6240; [18F]MK‐6240; florquinitau; neurofibrillary tangles; positron emission tomography; tau; tracer; visual read.

PubMed Disclaimer

Conflict of interest statement

J. Shuping is a consultant to Enigma Biomedical Group. C. Wilde was a consultant to Cerveau Technologies. J. Evelhoch, W. Kreisl, K. Johnson, C. Rowe, and K. Van Laere are consultants/advisors to Cerveau Technologies. D. Matthews, A. Lukic, and R. Andrews are employees of ADM Diagnostics, Inc. D. Scott, K. Adamczuk, J. Barakos, and D. Purcell are employees of Clario. C. Rowe is an employee of Austin Health, Melbourne and University of Melbourne, Australia. S. Johnson is an employee of the University of Wisconsin Madison. W. Kreisl, A. Brickman, D. Devanand, J. Luchsinger, Y. Stern, and P. Lao are employees of Columbia University. P. Rosa‐Neto is an employee of McGill University. K. Van Laere is an employee of UZ Leuven. K. Johnson and J. Price are employees of Massachusetts General Hospital and Harvard University. A. Boxer is an employee of the University of California San Francisco. W. Klunk is an employee of the University of Pittsburgh. C. Sur was an employee of Merck & Co., Inc. L. Cordes is an employee of StatKing Clinical Services. L. Ward is an employee of Florey Department of Neuroscience and Mental Health and University of Melbourne. S. Mathotaarachchi is an employee of Enigma Biomedical Group. Author disclosures are available in the supporting information.

Figures

FIGURE 1
FIGURE 1
Process overview of visual read method development with expert reader input, development of a gold standard read set, initial validation based upon read of the gold standard set by two naïve readers, selection of 131 scans for reading by two independent trained readers to provide further testing, and application of the visual read method to the full database of 1842 [18F]MK‐6240 PET scans. MRI, magnetic resonance imaging; PET, positron emission tomography; SUVR, standardized uptake value ratio
FIGURE 2
FIGURE 2
Examples of the four read classifications of the [18F]MK‐6240 read method: (A) no uptake, (B) MTL only, (C) MTL And, and (D) outside MTL. Images are displayed as PET only at left, and superimposed and display‐thresholded on co‐registered, spatially normalized MRI scans at right. It can be seen that elevated uptake is apparent in both the displays of PET‐only and PET thresholded and superimposed on MRI underlay. Images were contrast adjusted to display the range of intensities from just above cerebellar cortex signal to high intensity. While these are not SUVR images, the approximate voxel range of elevated uptake values referenced to cerebellar cortex is from 1.35 to 5 in these images although higher values are observed depending on subject and scanner. MRI, magnetic resonance imaging; PET, positron emission tomography; SUVR, standardized uptake value ratio
FIGURE 3
FIGURE 3
(A,B) “MTL only” with (A) emerging perirhinal/entorhinal signal and (B) spread producing a sagittal “hook” appearance associated with Braak Stage III involvement of entorhinal cortex, hippocampus, and amygdala; (C–E) “MTL AND” with (C) right hemisphere spread into right lateral temporal cortex, (D) asymmetric right hemispheric widespread cortical deposition, and (E) bilateral widespread cortical accumulation. Images also show various display states of smoothed (A,B), unsmoothed (inverted gray C, D, E), inverted gray and color tables, PET‐only and thresholded and superimposed on MRI. Images are from five different participants. Images were contrast adjusted to display range from cerebellar cortex signal to high intensity; the overlay PET images were display thresholded to exclude cerebellar cortex signal levels. MRI, magnetic resonance imaging; PET, positron emission tomography
FIGURE 4
FIGURE 4
(A) Read classification distribution for full database; (B–D) read classifications for scans of participants with (B) reported amyloid negative (A–) or (C) amyloid positive (A+) status and clinical diagnoses of cognitively unimpaired (CU), mild cognitive impairment (MCI), and Alzheimer's dementia (AD), (D) clinical diagnosis of traumatic brain injury (TBI), amyloid negative and positive. *It is noted that six of eight participants with a clinical diagnosis of AD, negative amyloid status, and “MTL and” classification are from a single site

References

    1. DeTure, MA , Dickson, DW. The neuropathological diagnosis of Alzheimer's disease. Mol Neurodegeneration. 2019;14:32. doi:10.1186/s13024-019-0333-5 - DOI - PMC - PubMed
    1. Hanseeuw BJ, Betensky RA, Jacobs HL, et al. Association of amyloid and tau with cognition in preclinical Alzheimer disease: a longitudinal study. JAMA Neurol. 2019;76(8):915‐924. - PMC - PubMed
    1. Arriagada PV, Growdon JH, Hedley‐Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 1992a;42:631‐639. - PubMed
    1. Nelson PT, Alafuzoff I, Bigio EH, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature, J Neuropathol Exp. Neurol. 2012;71:362‐381. - PMC - PubMed
    1. Walji AM, Hostetler ED, Selnick H, et al. Discovery of 6‐(Fluoro‐(18)F)‐3‐(1H‐pyrrolo[2,3‐c]pyridin‐1‐yl)isoquinolin‐5‐amine ([(18)F]‐MK‐6240): a positron emission tomography (PET) imaging agent for quantification of neurofibrillary tangles (NFTs). J Med Chem. 2016;59:4778‐4789. - PubMed